Diflunisal in the management of sprains.

A double-blind randomized trial was carried out in 31 patients suffering from acute, minor ligamentous injuries to compare the efficacy of diflunisal in the relief of pain with that of oxyphenbutazone. Patients received either 500 mg diflunisal twice daily or 200 mg oxyphenbutazone 3-times daily for 3 days. The results of subjective assessments showed tha by Day 3 spontaneous pain had either completely resolved or markedly improved in all patients, and that diflunisal was significantly better than oxyphenbutazone on Days 1 and 3 in relieving pain on movement of the joint.
AuthorsI D Adams
JournalCurrent medical research and opinion (Curr Med Res Opin) Vol. 5 Issue 7 Pg. 580-3 ( 1978) ISSN: 0300-7995 [Print] ENGLAND
PMID359254 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Analgesics
  • Biphenyl Compounds
  • Oxyphenbutazone
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Analgesics (adverse effects, therapeutic use)
  • Biphenyl Compounds (adverse effects, therapeutic use)
  • Clinical Trials as Topic
  • Female
  • Humans
  • Male
  • Middle Aged
  • Oxyphenbutazone (adverse effects, therapeutic use)
  • Pain (drug therapy)
  • Sprains and Strains (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: